- Advertisement -

FUJIFILM Cellular Dynamics in Agreement with Sana Biotechnology to Develop iPSC-Derived Cell Therapies – BioPharm International

Sana will be authorized to use the iPSC cell lines from FUJIFILM Cellular Dynamics for the research and development, clinical and commercial manufacture, and...

China, Public Health, International Relations And Biotechnology – Analysis – Eurasia Review

The announcement by Dr. He Jiankui on YouTube that he used CRISPR-Cas9, a gene-editing technology, to edit the genes of twins was a timely...

Organ-on-a-Chip: Big Questions Surrounding Regulation and the Roadmap to Broad Adoption

REGISTER NOW Broadcast Date:  Friday, May 10, 2024Time:  8:00 am PT, 11:00 am ET, 17:00 CEST Organ-on-a-chip (OOC) technologies are now being used...

New avenues to reduce long-term complications in preterm infants

Congenital hypogonadotropic hypogonadism is a rare disease characterized by delayed puberty or the complete absence of puberty in adolescence, leading to infertility. Some forms...

siRNAs May Provide New Approach to Fight Antibiotic-Resistant Bacterial Infections

Given the growing antibiotic resistance crisis, novel ways to target bacterial infections are becoming increasingly important. One potential strategy is to manipulate bacterial genes...

Implants Speed CAR T Cell Processing In Vivo, Treating Lymphoma in...

Researchers from North Carolina State University (NC State) and the University of North Carolina (UNC) at Chapel Hill have developed a “bioinstructive” implantable scaffold...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...

more new items

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Base Editing Strategy Alleviates Huntington’s Disease in Mice

According to at least one estimate, approximately 41,000 people in the United States have symptoms of Huntington’s disease, and more than 200,000 are at-risk...